Aclaris Therapeutics (ACRS) Revenue (2017 - 2026)
Aclaris Therapeutics (ACRS) posted Revenue of $1.63 million for Q2 2026, down 8.3% from $1.78 million a year earlier and down 18.4% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Revenue (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Aclaris Therapeutics was $8.22 million, down 51.0% year-over-year; for FY2025, it was $7.83 million, down 58.2% from FY2024.
- Annual Revenue shows a five-year compound annual growth rate of 3.8% (FY2020 to FY2025).
- In prior years, Aclaris Therapeutics' Revenue was $18.72 million in FY2024 (-40.1%), $31.25 million in FY2023 (+5.0%), $29.75 million in FY2022 (+340.1%) and $6.76 million in FY2021 (+4.3%).
- Quarterly Revenue has run from a low of $1.3 million in Q4 2025 to a high of $19.02 million in Q3 2022 over five years.
- On a year-over-year basis, Revenue increased in 1 of the last eight quarters, with an average decline of 32.1%.
- The strongest year-over-year quarter for Revenue in the past five years was Q4 2022, with growth of 416.5%; the weakest was Q4 2025, with a decline of 85.9%.
- According to Business Quant data, Revenue for the three prior quarters was $2 million (Q1 2026), $1.3 million (Q4 2025) and $3.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Aclaris Therapeutics | 540.26 Mn | 156.62 Mn | 1.41 Mn | 1.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.63 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 1.78 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Sep 30, 2024 | 4.35 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 17.57 Mn |
| Sep 30, 2023 | 9.28 Mn |
| Jun 30, 2023 | 1.87 Mn |
| Mar 31, 2023 | 2.53 Mn |
| Dec 31, 2022 | 7.75 Mn |
| Sep 30, 2022 | 19.02 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 1.45 Mn |
| Dec 31, 2021 | 1.50 Mn |
| Sep 30, 2021 | 1.66 Mn |
API Access
Aclaris Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();